Bernard Rubin

3.7k citations
42 papers · 3.3k · 1 hit paper · h-index 22

Impact in

Papers in

Bernard Rubin

41 papers receiving 2.4k citations

Bernard Rubin's Hit Papers

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents 1977 · 1.6k citations
1.6k0+16+32Years since publication50010001.5k

Peers

Bernard Rubin
Comparison fields: 5 of 76
  • Cardiology and Cardiovascular Medicine 1.3k
  • Cellular and Molecular Neuroscience 201
  • Genetics 103
  • Biochemistry 29
  • Endocrine and Autonomic Systems 36
Replace Emily F. Sabo with:
Emily F. Sabo United States
David J. Carini United States
Pamela A. Benfield United States
Edgar H. Ulm United States
W. A. M. Duncan United Kingdom
Saleem Ahmad United States
Enar I. Carlsson Sweden
Mario Bigioni Italy
Douglas W. Harris United States
Takeshi Fujita Japan
Bernard Rubin relative to Emily F. Sabo United States Emily F. Sabo's profile →
Citations per field
00.5×2×4×6×
Emily F. Sabo · 1×
Citations per year

Countries citing papers authored by Bernard Rubin

Since Specialization
Citations

This map shows the geographic impact of Bernard Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Rubin more than expected).

Fields of papers citing papers by Bernard Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Rubin. The network helps show where Bernard Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Rubin Line = papers co-authored together Bernard Rubin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
Hit paper breakdown →
19771609
2 1978192
3 1970162
4 1978157
5 1972129
6 1957113
7 1978105
8 197987
9 198061
10 198061
11 197858
12 197354
13
A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.
196453
14 196953
15
Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
197944
16 198941
17 197837
18 197930
19 198930
20 195229

About Bernard Rubin

Bernard Rubin is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Pharmacology, Cellular and Molecular Neuroscience and Genetics, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (21 papers), Inflammatory mediators and NSAID effects (2 papers), Neuropeptides and Animal Physiology (2 papers), Plant-based Medicinal Research (1 paper), Folate and B Vitamins Research (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Tuberculosis Research and Epidemiology (1 paper) and Alkaloids: synthesis and pharmacology (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Cellular and Molecular Neuroscience (201 citations), Genetics (103 citations), Biochemistry (29 citations) and Endocrine and Autonomic Systems (36 citations). Bernard Rubin has collaborated with scholars based in United States. Frequent co-authors include Miguel A. Ondetti, David W. Cushman, Michael J. Antonaccio, Robert J. Laffan, Zola P. Horovitz, John C. Burke, M.E. Goldberg, John P. High, Thomas R. Schaeffer and Stanford L. Engel. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Experimental Biology and Medicine, European Journal of Pharmacology, Hypertension and Clinical and Experimental Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact